Choruss’s Covenant: The Promised Land (Maybe) For Record Labels; A Lesser Destination For Everyone Else 17/03/2009 by Intellectual Property Watch 7 Comments Bennett Lincoff writes: If Choruss abandons the time-tested approach of licensing and relies instead on covenants not to sue, it will facilitate a brazen money grab by the major labels it represents, leaving songwriters, recording artists and music publishers empty-handed, and college students holding the bag.
New Medical Technologies Bring New IP Challenges 17/03/2009 by Catherine Saez and Kaitlin Mara for Intellectual Property Watch Leave a Comment LYON, FRANCE – At the cutting edge of medical technology lie new hopes for patients, but also serious ethical concerns and potential intellectual property snags. Read More…
Sigue La Expansion De Los Alcances De La Propiedad Intelectual 17/03/2009 by Intellectual Property Watch 1 Comment Santiago Roca escriba: La Unión Europea está solicitando mas extensiones en propiedad intelectual que los Estados Unidos de Norteamérica en la negociación del tratado de libre comercio.
Kenya Conference: Financial Incentives Needed For Tailored Neglected Disease Research 16/03/2009 by Nicholas Wadhams for Intellectual Property Watch Leave a Comment NAIROBI – Governments in Kenya and other developing nations must be willing to provide financial incentives if they expect companies to carry out research and development of drugs specifically tailored to those countries’ needs, a conference in Nairobi was told last week.
Record Cybersquatting Cases As WIPO Seeks New Trademark Protections 16/03/2009 by William New, Intellectual Property Watch 2 Comments A record number of cybersquatting complaints were filed at the World Intellectual Property Organization in 2008, and the organisation is preparing for a potentially much larger set of concerns as the launch of an unknown number of new domains approaches.
New Thinking On Biotech Patents From Industry Groups 13/03/2009 by Kaitlin Mara for Intellectual Property Watch 1 Comment LYON, FRANCE – A new level of willingness to cooperate on major public health initiatives may indicate increased convergence in goals between large pharmaceutical companies and patient advocacy groups, particularly when addressing neglected diseases, a panel at an international life sciences conference said Monday.
World Health Organization Issues Statement On Generic Drug Seizures 13/03/2009 by William New, Intellectual Property Watch Leave a Comment The World Health Organization on Friday issued a statement on a high-profile debate over Dutch customs authorities’ delays of shipments of legitimate generic pharmaceuticals passing through the European country on their way to patients in developing countries. The goods were apparently believed to be counterfeit medicines.
Deferred Examination: A Solution Whose Time Has Come 12/03/2009 by Intellectual Property Watch 2 Comments With over 1 million patent applications backlogged at the US Patent & Trademark Office, IBM legal counsel Steven Bennett and David Kappos urge adoption of a deferred examination process, which they argue will benefit USPTO, applicants and the public.
Lamy Restarts Informal WTO Process On Proposals On IP And Biodiversity, GI Extension 12/03/2009 by Kaitlin Mara for Intellectual Property Watch 2 Comments World Trade Organization Director General Pascal Lamy on Wednesday kicked off informal talks on two key intellectual property issues that have been stalled by disagreements on the forum and mandate for their discussion.
ICANN To IP Experts: Come Back With A Solution For Internet Trademark Protection 12/03/2009 by Monika Ermert for Intellectual Property Watch 2 Comments Trademark issues are emerging with the upcoming introduction of new generic top-level domains on the internet, and the board members of the body introducing the names has passed the ball back to intellectual property experts to find answers.